Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation

被引:38
作者
Hayashi, Y
Sawa, Y
Ohtake, S
Fukuyama, N
Nakazawa, H
Matsuda, H
机构
[1] Osaka Univ, Sch Med, Course Intervent Med E1, Dept Surg, Suita, Osaka 5650871, Japan
[2] Tokai Univ, Sch Med, Dept Physiol 2, Kanagawa, Japan
关键词
D O I
10.1016/S0003-4975(01)02668-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Current experimental studies have demonstrated that peroxynitrite (ONOO-) has both cytotoxic and cytoprotective effects on myocardial ischemia-reperfusion injury. However, even myocardial ONOO- formation has not yet been investigated in humans undergoing open heart operation. We measured plasma nitrotyrosine as an indicator of ONOO- formation during open heart operation and examined its association with myocardial ischemia-reperfusion injury. Methods. Twenty adult patients undergoing mitral valve replacement under cardiopulmonary bypass between 1997 and 1998 were enrolled in this study (6 men and 14 women). Arterial blood (Ao) and coronary sinus effluent (CS) were obtained: (1) before the initiation of cardiopulmonary bypass, (2) just after aortic unclamping, (3) at 5 minutes, (4) at 10 minutes, (5) at 15 minutes, and (6) at 20 minutes after aortic unclamping. Results. At every sampling point after reperfusion, plasma nitrate and nitrite was significantly lower in CS than in Ao, and the percentage ratio of nitrotyrosine to tyrosine (%NO2-Tyr; an index of ONOO- formation) was significantly higher in CS than in Ao. The CS-Ao difference in %NO2-Tyr, myocardium-derived ONOO-, reached its peak at 5 minutes after reperfusion (2.17 +/- 0.74%), which was significantly correlated with the peak CS-Ao difference in plasma malondialdehyde, and with postoperative maximum creatine kinase-MB. Conclusions. These results first demonstrate that ONOO- is produced from human myocardium after ischemia-reperfusion during open heart operation, and myocardium-derived ONOO- can be determined by the CS-Ao difference in %NO2-Tyr. (C) 2001 by The Society of Thoracic Surgeons.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 32 条
  • [1] APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE
    BECKMAN, JS
    BECKMAN, TW
    CHEN, J
    MARSHALL, PA
    FREEMAN, BA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) : 1620 - 1624
  • [2] XANTHINE-OXIDASE AS A SOURCE OF FREE-RADICAL DAMAGE IN MYOCARDIAL ISCHEMIA
    CHAMBERS, DE
    PARKS, DA
    PATTERSON, G
    ROY, R
    MCCORD, JM
    YOSHIDA, S
    PARMLEY, LF
    DOWNEY, JM
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1985, 17 (02) : 145 - 152
  • [3] RELEASE OF VASOACTIVE SUBSTANCES DURING CARDIOPULMONARY BYPASS
    DOWNING, SW
    EDMUNDS, LH
    [J]. ANNALS OF THORACIC SURGERY, 1992, 54 (06) : 1236 - 1243
  • [4] Formation of nitric oxide derived inflammatory oxidants by myeloperoxidase in neutrophils
    Eiserich, JP
    Hristova, M
    Cross, CE
    Jones, AD
    Freeman, BA
    Halliwell, B
    van der Vliet, A
    [J]. NATURE, 1998, 391 (6665) : 393 - 397
  • [5] L-ARGININE REDUCES ENDOTHELIAL INFLAMMATION AND MYOCARDIAL STUNNING DURING ISCHEMIA-REPERFUSION
    ENGELMAN, DT
    WATANABE, M
    MAULIK, N
    CORDIS, GA
    ENGELMAN, M
    ROUSOU, JA
    FLACK, JE
    DEATON, DW
    DAS, DK
    [J]. ANNALS OF THORACIC SURGERY, 1995, 60 (05) : 1275 - 1281
  • [6] FAYMONVILLE ME, 1991, J THORAC CARDIOV SUR, V102, P309
  • [7] Peroxynitrite formation from activated human leukocytes
    Fukuyama, N
    Ichimori, K
    Su, Z
    Ishida, H
    Nakazawa, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (02) : 414 - 419
  • [8] Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock
    Fukuyama, N
    Takebayashi, Y
    Hida, M
    Ishida, H
    Ichimori, K
    Nakazawa, H
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (05) : 771 - 774
  • [9] ANALYSIS OF NITRATE, NITRITE, AND [N-15]-LABELED NITRATE IN BIOLOGICAL-FLUIDS
    GREEN, LC
    WAGNER, DA
    GLOGOWSKI, J
    SKIPPER, PL
    WISHNOK, JS
    TANNENBAUM, SR
    [J]. ANALYTICAL BIOCHEMISTRY, 1982, 126 (01) : 131 - 138
  • [10] Controlled nicorandil administration for myocardial protection during coronary artery bypass grafting under cardiopulmonary bypass
    Hayashi, Y
    Sawa, Y
    Ohtake, S
    Nishimura, M
    Ichikawa, H
    Matsuda, H
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (01) : 21 - 28